Skip to main content
UCSF Gynecology Oncology Division

Gynecologic Oncology Research

Cancer Risk Program Research

Lee-may Chen, M.D.
Hereditary Nonpolyposis Colorectal Cancer / Lynch Syndrome Project
The cost-effectiveness of various surveillance and risk-reduction strategies with regards to gynecologic cancer risk will be determined. The factors associated with decision making in women with Lynch Syndrome will be investigated, and endometrial cancer patients at risk for Lynch Syndrome will be identified through evaluation of pathology specimens.

Hereditary Breast / Ovarian Cancer Syndrome Project
The surgical outcomes of combining risk reducing gynecologic surgery with breast and reconstructive surgery will be evaluated, along with outcomes of specific histopathologies of ovarian/peritoneal/tubal carcinoma as they may relate to BRCA1 and BRCA2 germline mutations.

Hereditary Gynecologic Cancer Risk Clinic 
A multidisciplinary clinic will be established offering consultation to families at high genetic risk for gynecologic cancers, assess familial pedigrees and test members for specific gene mutations. This program will investigate the benefit of risk reduction surgeries and management programs and will also train medical residents in risk identification.   A large database of identified families with hereditary risk will be maintained.

Medical Education Research

Lee-may Chen, M.D.
Medical Education Project
The most highly valued characteristics in selecting surgical residents will be determined, along with the relative values of these characteristics. The career outcomes of top-ranked residency applicants to the UCSF obstetrics & gynecology residency program will be evaluated. A validated healthcare matrix will be developed and applied for linking gynecologic oncology quality assurance with educational competencies in an Obstetrics & Gynecology training program.

Symptom Management Program

Lee-may Chen, M.D.
Symptom Management Program project
This study aims to determine whether perioperative epidural analgesia in gynecologic oncology patients, when compared to PCA, improves the management of postoperative pain and is associated with a change in postoperative outcomes.